MetLife (MET) Director Robert Glenn Hubbard Receives 618 Shares

What Happened

• Robert Glenn Hubbard, a non-management director of MetLife, reported an acquisition of 618 shares of MetLife common stock on 2026-09-08. The reported price per share was $95.50, for a total value of $59,019.
• This transaction is an acquisition (transaction code A) resulting from imputed reinvestment of dividends on deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors, not an open-market purchase.

Key Details

• Transaction date: 2026-09-08; Filing date (Form 4): 2026-09-10.
• Price per share: $95.50; Total value: $59,019.
• Shares acquired: 618.
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: The shares reflect imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors — deferred shares have become payable but the director has elected to defer receipt.

Context

• This is an administrative acquisition from dividend reinvestment in a deferred-compensation program rather than an active open-market buy. Such reinvestments are routine and reflect plan mechanics, not necessarily a new purchase decision by the insider.